Search Results 51-60 of 17283 for egfr

1. Researchers Use Genomic Sequencing to Help Identify New Therapies for Bile Duct Cancer - Mayo Clinic News Network

   Study targets EGFR and FGFR cellular pathways to treat rare disease. SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic's Center for ...

2. A Study Of Rociletinib (CO-1686) For Patients With A Mutant Form Of Non-Small Cell Lung Cancer. - Mayo Clinic

   To provide access to rociletinib for patients with advanced or metastatic EGFR-mutant NSCLC who have been treated previously with EGFR directed therapy and have ...

3. Amivantamab-vmjw (intravenous route) - Side effects & uses - Mayo Clinic

   ... (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). This medicine is also used in combination with carboplatin and pemetrexed to treat ...

4. A Study to Compare the Effectiveness of Invasive versus Conservative Medical Approaches in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease - Mayo Clinic

   ... [eGFR] <30 or on dialysis). This is a multicenter randomized controlled trial with a target randomization of ~1000 patients with advanced CKD and at least ...

5. A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

   ... EGFR- or MET-based resistance to a third-generation EGFR TKI, and potential recruitment of Fc-bearing immune cells in the anti-tumor response. The ...

6. A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer - Mayo Clinic

   Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

7. Gefitinib (oral route) - Side effects & dosage - Mayo Clinic

   ... (EGFR) genes, and did not receive cancer medicines in the past. Your doctor will perform a test before you take this medicine. Gefitinib belongs to the group ...

8. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

   ... (eGFR > 60 mL/min/m2, BP<130/90 mmHg), and these correlate with defects in isolated endothelial cells. Participation eligibility. Participant eligibility ...

9. A Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Anti-tumor Activity Of WSD0922-FU - Mayo Clinic

   Participation eligibility · Diagnosis: Histological confirmation of either glioblastoma, IDH wildtype (GBM) or anaplastic astrocytoma, IDH wildtype (AA); · EGFR ...

10. Publications - Lida A. Mina, M.D. - Mayo Clinic

    Complete Imaging Resolution of Ductal Carcinoma In Situ During Osimertinib Therapy for Synchronous EGFR Exon 19-Mutant Non-Small Cell Lung Cancer: A Case Report ...